You are seeing this message because your Web browser does not support basic Web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.


ABOUT ARCHIVES
Advanced Search

Welcome   | My Account | E-mail Alerts | Access Rights | Sign In


  Vol. 133 No. 5, May 1998 TABLE OF CONTENTS
  Archives
  •  Online Features
  Basic Sciences
 This Article
 •Full text
 •PDF
 •Send to a friend
 • Save in My Folder
 •Save to citation manager
 •Permissions
 Citing Articles
 •Citation map
 •Citing articles on HighWire
 •Citing articles on ISI (60)
 •Contact me when this article is cited
 Related Content
 •Similar articles in this journal
 Topic Collections
 •Surgery, Other
 •Alert me on articles by topic

Revisiting the Role of Tumor Necrosis Factor {alpha} and the Response to Surgical Injury and Inflammation

Riadh Ksontini, MD; Sally L. D. MacKay, PhD; Lyle L. Moldawer, PhD

Arch Surg. 1998;133:558-567.

Tumor necrosis factor {alpha} (TNF-{alpha}) is a pleiotropic cytokine with diverse biological actions. Studies originally identified TNF-{alpha} as a systemic mediator of endotoxemic shock, cachexia, and tumor regression. We now recognize that TNF-{alpha} is a member of a large family of proteins, including Fas ligand, whose actions are primarily paracrine in nature, and serve to regulate both cell proliferation and apoptotic death. Although clinical trials with TNF-{alpha} inhibitors in sepsis syndrome have been disappointing to date, and TNF-{alpha} administration has not proven widely successful as an antineoplastic agent, preliminary successes with TNF-{alpha} inhibition have been recently reported in more chronic inflammatory diseases, including rheumatoid arthritis and ulcerative colitis. The recent description of the TNF-{alpha} converting enzyme responsible for the processing of cell-associated to secreted TNF-{alpha} has opened a new therapeutic avenue to address inflammatory diseases dependent on the release of 17-kd secreted TNF-{alpha}. Similarly, inhibitors of nuclear factor Kappa B activation can increase TNF-{alpha}–mediated apoptosis and have rejuvenated efforts to explore TNF-{alpha}'s antineoplastic potential. The multiple and often conflicting TNF-{alpha} signaling pathways reveal a diversity to TNF-{alpha}'s actions not fully appreciated in the past. Such investigations have opened a number of novel therapeutic interventions to either inhibit or potentiate the actions of TNF-{alpha} during surgical injury or acute inflammation.


From the Department of Surgery, University of Florida College of Medicine, Gainesville.



THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

TNF-{alpha} Coupled to Membrane of Apoptotic Cells Favors the Cross-Priming to Melanoma Antigens
Zimmermann et al.
J. Immunol. 2004;172:2643-2650.
ABSTRACT | FULL TEXT  

Acute mast cell-dependent neutrophil recruitment in the skin is mediated by KC and LFA-1: inhibitory mechanisms of dexamethasone
Schramm et al.
J. Leukoc. Biol. 2002;72:1122-1132.
ABSTRACT | FULL TEXT  

Inhibition of muscle insulin-like growth factor I expression by tumor necrosis factor-alpha
Fernandez-Celemin et al.
Am. J. Physiol. Endocrinol. Metab. 2002;283:E1279-E1290.
ABSTRACT | FULL TEXT  

TNF-{alpha} Induces Apoptosis of Lactotropes from Female Rats
Candolfi et al.
Endocrinology 2002;143:3611-3617.
ABSTRACT | FULL TEXT  

Genetic determinants of lipopolysaccharide and D-galactosamine-mediated hepatocellular apoptosis and lethality
Oberholzer et al.
Innate Immunity 2001;7:375-380.
ABSTRACT  

The Role of Tumor Necrosis Factor-alpha (TNF-{alpha}) in Skeletal Muscle Regeneration: Studies in TNF-{alpha}(-/-) and TNF-{alpha}(-/-)/LT-{alpha}(-/-) Mice
Collins and Grounds
J. Histochem. Cytochem. 2001;49:989-1002.
ABSTRACT | FULL TEXT  

Compensatory hepatic regeneration after mild, but not fulminant, intraperitoneal sepsis in rats
Weiss et al.
Am. J. Physiol. Gastrointest. Liver Physiol. 2001;280:G968-G973.
ABSTRACT | FULL TEXT  

Linomide abolishes leukocyte adhesion and extravascular recruitment induced by tumor necrosis factor {alpha}in vivo
Zhang et al.
J. Leukoc. Biol. 2000;68:621-626.
ABSTRACT | FULL TEXT  

Enhanced Murine Macrophage TNF Receptor Shedding by Cytosine-Guanine Sequences in Oligodeoxynucleotides
Jin et al.
J. Immunol. 2000;165:5153-5160.
ABSTRACT | FULL TEXT  

Leaks in the epithelial barrier caused by spontaneous and TNF-{alpha}-induced single-cell apoptosis
GITTER et al.
FASEB J. 2000;14:1749-1753.
ABSTRACT | FULL TEXT  

LPS-induced liver injury in D-galactosamine-sensitized mice requires secreted TNF-alpha and the TNF-p55 receptor
Nowak et al.
Am. J. Physiol. Regul. Integr. Comp. Physiol. 2000;278:R1202-R1209.
ABSTRACT | FULL TEXT  

TNF-{alpha} Receptor Signaling and IL-10 Gene Therapy Regulate the Innate and Humoral Immune Responses to Recombinant Adenovirus in the Lung
Minter et al.
J. Immunol. 2000;164:443-451.
ABSTRACT | FULL TEXT  

Sensitization of Tumor Necrosis Factor {{alpha}}-resistant Human Melanoma by Tumor-specific in Vivo Transfer of the Gene Encoding Endothelial Monocyte-activating Polypeptide II Using Recombinant Vaccinia Virus
F. X. Gnant et al.
Cancer Res. 1999;59:4668-4674.
ABSTRACT | FULL TEXT  

Identification of Tumor Necrosis Factor (TNF) Amino Acids Crucial for Binding to the Murine p75 TNF Receptor and Construction of Receptor-selective Mutants
Ameloot et al.
J. Biol. Chem. 2001;276:37426-37430.
ABSTRACT | FULL TEXT  





HOME | CURRENT ISSUE | PAST ISSUES | TOPIC COLLECTIONS | CME | SUBMIT | SUBSCRIBE | HELP
CONDITIONS OF USE | PRIVACY POLICY | CONTACT US | SITE MAP
 
© 1998 American Medical Association. All Rights Reserved.